REACTIVATION OF HUMAN ENDOGENOUS RETROVIRUSES (HERV-W) AS A GENETIC-IMMUNOLOGICAL TRIGGER OF PSYCHOSIS: A REVIEW OF THE NEUROTOXIC MECHANISMS OF THE ENVELOPE PROTEIN (ENV)
DOI:
https://doi.org/10.31435/ijitss.1(49).2026.5283Keywords:
HERV-W, Schizophrenia, Neuroinflammation, Pyroptosis, TemelimabAbstract
Schizophrenia does not arise from a single genetic flaw or a solitary environmental insult; rather, it is born from the collision of both. In this review, we move beyond classical neurotransmitter theories to dissect the molecular pathogenicity of the Human Endogenous Retrovirus-W Envelope protein (HERV-W ENV). We trace the evolution of the historical "viral hypothesis" into the modern "two-hit" model, wherein environmental stressors literally awaken dormant retroviral elements within our own DNA. How does this intragenomic parasite damage the brain? We evaluate its neurotoxicity across three distinct pillars: structural, immunological, and signaling. Structurally, the protein’s fusogenic properties induce severe membrane instability. Immunologically, it acts as a potent toxin, igniting the microglial TLR4 cascade and driving neurons into violent, inflammatory death via the NLRP3-Caspase-1-GSDMD pyroptosis pathway. Yet, the most profound damage occurs within intracellular signaling. HERV-W ENV actively sabotages the dopamine-glutamate axis. It forces NMDA receptors to escape the synapse laterally, starves the synaptic cleft by blocking ASCT1/2-mediated glutamine transport, and hijacks the AKT/GSK3β pathway to drive dopaminergic hyperactivity. These integrated mechanisms establish HERV-W ENV not just as a bystander, but as a direct causal bridge between immune dysregulation and synaptic failure. Recognizing this distinct "inflammatory biotype" of psychosis completely alters the therapeutic landscape. We conclude by exploring how neutralizing this viral protein with the monoclonal antibody Temelimab could move the field from symptomatic management toward true etiological intervention in precision psychiatry.
References
Aftab, A., Shah, A. A., & Hashmi, A. M. (2016). Pathophysiological role of HERV-W in schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences, 28(1), 17–25. https://doi.org/10.1176/appi.neuropsych.15030059
Balestrieri, E., Matteucci, C., Cipriani, C., Grelli, S., Ricceri, L., Calamandrei, G., & Sinibaldi Vallebona, P. (2019). Endogenous retroviruses activity as a molecular signature of neurodevelopmental disorders. International Journal of Molecular Sciences, 20(23), 6050. https://doi.org/10.3390/ijms20236050
Crow, T. J. (1984). A re-evaluation of the viral hypothesis: Is psychosis the result of retroviral integration at a site close to the cerebral dominance gene? The British Journal of Psychiatry, 145(3), 243–253. https://doi.org/10.1192/bjp.145.3.243
Dou, A., Xu, J., & Zhou, C. (2025). The relationship between HERVs and exogenous viral infections: A focus on the value of HERVs in disease prediction and treatment. Virulence, 16(1), 2523888. https://doi.org/10.1080/21505594.2025.2523888
Durnaoglu, S., Lee, S. K., & Ahnn, J. (2022). Syncytin, envelope protein of human endogenous retrovirus (HERV): No longer “fossil” in human genome. Animal Cells and Systems, 25(6), 358–368. https://doi.org/10.1080/19768354.2021.2019109
Emamian, E. S. (2012). AKT/GSK3 signaling pathway and schizophrenia. Frontiers in Molecular Neuroscience, 5, 33. https://doi.org/10.3389/fnmol.2012.00033
Engel, M. E., & Hiebert, S. W. (2010). The enemy within: Dormant retroviruses awaken. Nature Medicine, 16(5), 517–518. https://doi.org/10.1038/nm0510-517
Feigenson, K. A., Kusnecov, A. W., & Silverstein, S. M. (2014). Inflammation and the two-hit hypothesis of schizophrenia. Neuroscience and Biobehavioral Reviews, 38, 72–93. https://doi.org/10.1016/j.neubiorev.2013.11.006
Giménez-Orenga, K., & Oltra, E. (2021). Human endogenous retrovirus as therapeutic targets in neurologic disease. Pharmaceuticals, 14(6), 495. https://doi.org/10.3390/ph14060495
Gong, R., Peng, X., Kang, S., Feng, H., Huang, J., Zhang, W., Lin, D., Tien, P., & Xiao, G. (2005). Structural characterization of the fusion core in syncytin, envelope protein of human endogenous retrovirus family W. Biochemical and Biophysical Research Communications, 331(4), 1193–1200. https://doi.org/10.1016/j.bbrc.2005.04.032
Hegyi, H. (2013). GABBR1 has a HERV-W LTR in its regulatory region: A possible implication for schizophrenia. Biology Direct, 8, 5. https://doi.org/10.1186/1745-6150-8-5
Hogan, V., & Johnson, W. E. (2023). Unique structure and distinctive properties of the ancient and ubiquitous gamma-type envelope glycoprotein. Viruses, 15(2), 274. https://doi.org/10.3390/v15020274
Hossain, M. J., Nyame, P., & Monde, K. (2024). Species-specific transcription factors associated with long terminal repeat promoters of endogenous retroviruses: A comprehensive review. Biomolecules, 14(3), 280. https://doi.org/10.3390/biom14030280
Huang, W. J., Liu, Z. C., Wei, W., Wang, G. H., Wu, J. G., & Zhu, F. (2006). Human endogenous retroviral pol RNA and protein detected and identified in the blood of individuals with schizophrenia. Schizophrenia Research, 83(2–3), 193–199. https://doi.org/10.1016/j.schres.2006.01.007
Jia, C., Zhang, M., Wu, X., Zhang, X., Lv, Z., Zhao, K., Zhang, J., Su, Y., & Zhu, F. (2025). HERV-W env induces neuron pyroptosis via the NLRP3–CASP1–GSDMD pathway in recent-onset schizophrenia. International Journal of Molecular Sciences, 26(2), 520. https://doi.org/10.3390/ijms26020520
Johansson, E. M., Bouchet, D., Tamouza, R., Ellul, P., Morr, A. S., Avignone, E., Germi, R., Leboyer, M., Perron, H., & Groc, L. (2020). Human endogenous retroviral protein triggers deficit in glutamate synapse maturation and behaviors associated with psychosis. Science Advances, 6(29), eabc0708. https://doi.org/10.1126/sciadv.abc0708
Karlsson, H., Bachmann, S., Schröder, J., McArthur, J., Torrey, E. F., & Yolken, R. H. (2001). Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proceedings of the National Academy of Sciences, 98(8), 4634–4639. https://doi.org/10.1073/pnas.061021998
Kornmann, G., & Curtin, F. (2020). Temelimab, an IgG4 anti-human endogenous retrovirus monoclonal antibody: An early development safety review. Drug Safety, 43(12), 1287–1296. https://doi.org/10.1007/s40264-020-00988-3
Küry, P., Nath, A., Créange, A., Dolei, A., Marche, P., Gold, J., Giovannoni, G., Hartung, H. P., & Perron, H. (2018). Human endogenous retroviruses in neurological diseases. Trends in Molecular Medicine, 24(4), 379–394. https://doi.org/10.1016/j.molmed.2018.02.007
Lavillette, D., Marin, M., Ruggieri, A., Mallet, F., Cosset, F. L., & Kabat, D. (2002). The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. Journal of Virology, 76(13), 6442–6452. https://doi.org/10.1128/jvi.76.13.6442-6452.2002
Leboyer, M., Tamouza, R., Charron, D., Faucard, R., & Perron, H. (2013). Human endogenous retrovirus type W (HERV-W) in schizophrenia: A new avenue of research at the gene-environment interface. The World Journal of Biological Psychiatry, 14(2), 80–90. https://doi.org/10.3109/15622975.2010.601760
Li, F., & Karlsson, H. (2016). Expression and regulation of human endogenous retrovirus W elements. APMIS, 124(1–2), 52–66. https://doi.org/10.1111/apm.12478
Li, X., Wu, X., Li, W., Yan, Q., Zhou, P., Xia, Y., Yao, W., & Zhu, F. (2023). HERV-W ENV induces innate immune activation and neuronal apoptosis via linc01930/cGAS axis in recent-onset schizophrenia. International Journal of Molecular Sciences, 24(3), 3000. https://doi.org/10.3390/ijms24033000
Meier, U. C., Cipian, R. C., Karimi, A., Ramasamy, R., & Middeldorp, J. M. (2021). Cumulative roles for Epstein-Barr virus, human endogenous retroviruses, and human herpes virus-6 in driving an inflammatory cascade underlying MS pathogenesis. Frontiers in Immunology, 12, 757302. https://doi.org/10.3389/fimmu.2021.757302
Mouliou, D. S., & Dardiotis, E. (2022). Temelimab for MS and SARS-CoV-2: Could it be a double-edged blessing? Multiple Sclerosis and Related Disorders, 64, 103938. https://doi.org/10.1016/j.msard.2022.103938
Palaniyappan, L., & Liddle, P. F. (2025). Seminal contributions of Timothy J. Crow. Psychological Medicine, 55, e75. https://doi.org/10.1017/S0033291725000182
Perron, H., Jouvin-Marche, E., Michel, M., Ounanian-Paraz, A., Camelo, S., Dumon, A., Jolivet-Reynaud, C., Marcel, F., Souillet, Y., Borel, E., et al. (2001). Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology, 287(2), 321–332. https://doi.org/10.1006/viro.2001.1045
Rangel, S. C., da Silva, M. D., Natrielli Filho, D. G., Santos, S. N., do Amaral, J. B., Victor, J. R., Silva, K. C. N., Tuleta, I. D., França, C. N., Shio, M. T., Neves, L. M., Bachi, A. L. L., & da Silva Nali, L. H. (2024). HERV-W upregulation expression in bipolar disorder and schizophrenia: Unraveling potential links to systemic immune/inflammation status. Retrovirology, 21(1), 7. https://doi.org/10.1186/s12977-024-00640-3
Rolland, A., Jouvin-Marche, E., Viret, C., Faure, M., Perron, H., & Marche, P. N. (2006). The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. The Journal of Immunology, 176(12), 7636–7644. https://doi.org/10.4049/jimmunol.176.12.7636
Scalise, M., Mazza, T., Pappacoda, G., Pochini, L., Cosco, J., Rovella, F., & Indiveri, C. (2020). The human SLC1A5 neutral amino acid transporter catalyzes a pH-dependent glutamate/glutamine antiport, as well. Frontiers in Cell and Developmental Biology, 8, 603. https://doi.org/10.3389/fcell.2020.00603
Sighencea, M. G., & Trifu, S. C. (2025). Unravelling the viral hypothesis of schizophrenia: A comprehensive review of mechanisms and evidence. International Journal of Molecular Sciences, 26(15), 7429. https://doi.org/10.3390/ijms26157429
Simula, E. R., Jasemi, S., Cossu, D., Fais, M., Cossu, I., Chessa, V., Canu, M., & Sechi, L. A. (2025). Human endogenous retroviruses as novel therapeutic targets in neurodegenerative disorders. Vaccines, 13(4), 415. https://doi.org/10.3390/vaccines13040415
Slokar, G., & Hasler, G. (2016). Human endogenous retroviruses as pathogenic factors in the development of schizophrenia. Frontiers in Psychiatry, 6, 183. https://doi.org/10.3389/fpsyt.2015.00183
Tamouza, R., Meyer, U., Foiselle, M., Richard, J. R., Wu, C. L., Boukouaci, W., Le Corvoisier, P., Barrau, C., Lucas, A., Perron, H., & Leboyer, M. (2021). Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis. Translational Psychiatry, 11(1), 377. https://doi.org/10.1038/s41398-021-01499-0
Wang, X., Huang, J., & Zhu, F. (2018). Human endogenous retroviral envelope protein syncytin-1 and inflammatory abnormalities in neuropsychological diseases. Frontiers in Psychiatry, 9, 422. https://doi.org/10.3389/fpsyt.2018.00422
Wang, X., Wu, X., Huang, J., Li, H., Yan, Q., & Zhu, F. (2021). Human endogenous retrovirus W family envelope protein (HERV-W env) facilitates the production of TNF-α and IL-10 by inhibiting MyD88s in glial cells. Archives of Virology, 166(4), 1035–1045. https://doi.org/10.1007/s00705-020-04933-8
Wieland, L., Schwarz, T., Engel, K., Volkmer, I., Krüger, A., Tarabuko, A., Junghans, J., Kornhuber, M. E., Hoffmann, F., Staege, M. S., & Emmer, A. (2022). Epstein-Barr virus-induced genes and endogenous retroviruses in immortalized B cells from patients with multiple sclerosis. Cells, 11(22), 3619. https://doi.org/10.3390/cells11223619
Wu, X., Liu, L., Xue, X., Li, X., Zhao, K., Zhang, J., Li, W., Yao, W., Ding, S., Jia, C., & Zhu, F. (2023). Captive ERVWE1 triggers impairment of 5-HT neuronal plasticity in the first-episode schizophrenia by post-transcriptional activation of HTR1B in ALKBH5-m6A dependent epigenetic mechanisms. Cell & Bioscience, 13(1), 213. https://doi.org/10.1186/s13578-023-01167-4
Xiao, R., Li, S., Cao, Q., Wang, X., Yan, Q., Tu, X., Zhu, Y., & Zhu, F. (2017). Human endogenous retrovirus W env increases nitric oxide production and enhances the migration ability of microglia by regulating the expression of inducible nitric oxide synthase. Virologica Sinica, 32(3), 216–225. https://doi.org/10.1007/s12250-017-3997-4
Yan, Q., Wu, X., Zhou, P., Zhou, Y., Li, X., Liu, Z., Tan, H., Yao, W., Xia, Y., & Zhu, F. (2022). HERV-W envelope triggers abnormal dopaminergic neuron process through DRD2/PP2A/AKT1/GSK3 for schizophrenia risk. Viruses, 14(1), 145. https://doi.org/10.3390/v14010145
Yao, W., Zhou, P., Yan, Q., Wu, X., Xia, Y., Li, W., Li, X., & Zhu, F. (2023). ERVWE1 reduces hippocampal neuron density and impairs dendritic spine morphology through inhibiting Wnt/JNK non-canonical pathway via miR-141-3p in schizophrenia. Viruses, 15(1), 168. https://doi.org/10.3390/v15010168
Yolken, R. H., Karlsson, H., Yee, P., Johnston-Wilson, N. L., & Torrey, E. F. (2000). Endogenous retroviruses and schizophrenia. Brain Research Reviews, 31(2–3), 193–199. https://doi.org/10.1016/S0165-0173(99)00037-5
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Jakub Robert Skalski, Łukasz Ćmok, Justyna Chudy, Julia Jadwiga Dobrowolska, Gabriela Daniel, Natalia Kaczmarczyk, Antoni Hajdas, Karolina Halat, Julia Szmuc, Iga Kałka
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
